RegenLab Switzerland
Ahmed Tewfik Beggah has a diverse background in clinical research and project management. With experience at various prestigious institutions such as CHUV and Regen Lab®, Ahmed has expertise in clinical investigations, regulatory affairs, quality compliance, and data management. Ahmed Tewfik holds a PhD in Biochemistry/Molecular Biology and advanced studies in Management in clinical trials from the University of Geneva.
This person is not in any teams
RegenLab Switzerland
RegenLab® is recognized as a certified global leader in medical biotechnologies, specializing in autologous platelet-rich plasma treatment. RegenLab® is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient's own blood. Regen® A-PRP® was developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over two million treatments provided worldwide using RegenLab® products. As we look to the future, the company is committed to guiding new standards for emerging categories within the field of regenerative medicine.